Christopher Whitehead
Keine laufenden Positionen mehr
Profil
Christopher Whitehead is the founder of Mekanistic Therapeutics LLC.
Prior to founding Mekanistic Therapeutics LLC, he worked as the Director of Operations & Strategy at Sierra Oncology, Inc. He holds a doctorate degree from Rensselaer Polytechnic Institute and an MBA from the University of Michigan.
Ehemalige bekannte Positionen von Christopher Whitehead
| Unternehmen | Position | Ende |
|---|---|---|
Mekanistic Therapeutics LLC
 Mekanistic Therapeutics LLC Pharmaceuticals: MajorHealth Technology Mekanistic Therapeutics LLC designs, discovers and develops cancer therapeutics through developing anti-cancer agents. The company was founded by Christopher Whitehead and Judith Sebolt-Leopold and is headquartered in Ann Arbor, MI. | Gründer | - |
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | - |
Ausbildung von Christopher Whitehead
| University of Michigan | Masters Business Admin |
| Rensselaer Polytechnic Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Mekanistic Therapeutics LLC
Mekanistic Therapeutics LLC Pharmaceuticals: MajorHealth Technology Mekanistic Therapeutics LLC designs, discovers and develops cancer therapeutics through developing anti-cancer agents. The company was founded by Christopher Whitehead and Judith Sebolt-Leopold and is headquartered in Ann Arbor, MI. | Health Technology |
